Mortality of cases with chronic kidney disease and its risk factors admitted to hospital with COVID-19 in Almaty city, Kazakhstan

Salud, Ciencia y Tecnología Pub Date : 2024-07-16 DOI:10.56294/saludcyt20241328

L. Garazhayeva, Gaipov Abduzhappar, Kauysheva Almagul

{"title":"Mortality of cases with chronic kidney disease and its risk factors admitted to hospital with COVID-19 in Almaty city, Kazakhstan","authors":"L. Garazhayeva, Gaipov Abduzhappar, Kauysheva Almagul","doi":"10.56294/saludcyt20241328","DOIUrl":null,"url":null,"abstract":"Aim: to determine the rate of mortality of cases with chronic kidney disease and its risk factors admitted to hospital with COVID-19 in Almaty City, Kazakhstan. Methods: Patients with coronavirus infections who were hospitalized at a hospital in the Kazakhstani Almaty region from June 2020 until June 2022 are included in the retrospective analysis. The Unified National Electronic Healthcare System (UNEHS) provided the database extraction. Individuals were considered eligible if they had been admitted to the hospital with the primary diagnoses of U07.1 (COVID-19, detected virus) and U07.2. Conclusion: In Almaty, Kazakhstan, hospitalization outcomes for coronavirus patients with and without chronic kidney disease were assessed in this study. Analysis was done on the impact of comorbidities and sociodemographic characteristics on mortality. While there are many ways to prevent and manage chronic kidney disease (CKD), coexisting medical diseases, particularly viruses that cause pandemics, might complicate matters. Thus, to prevent unplanned infectious disease outbreaks, a thorough disease management plan must be established","PeriodicalId":506303,"journal":{"name":"Salud, Ciencia y Tecnología","volume":" 20","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Salud, Ciencia y Tecnología","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56294/saludcyt20241328","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Aim: to determine the rate of mortality of cases with chronic kidney disease and its risk factors admitted to hospital with COVID-19 in Almaty City, Kazakhstan. Methods: Patients with coronavirus infections who were hospitalized at a hospital in the Kazakhstani Almaty region from June 2020 until June 2022 are included in the retrospective analysis. The Unified National Electronic Healthcare System (UNEHS) provided the database extraction. Individuals were considered eligible if they had been admitted to the hospital with the primary diagnoses of U07.1 (COVID-19, detected virus) and U07.2. Conclusion: In Almaty, Kazakhstan, hospitalization outcomes for coronavirus patients with and without chronic kidney disease were assessed in this study. Analysis was done on the impact of comorbidities and sociodemographic characteristics on mortality. While there are many ways to prevent and manage chronic kidney disease (CKD), coexisting medical diseases, particularly viruses that cause pandemics, might complicate matters. Thus, to prevent unplanned infectious disease outbreaks, a thorough disease management plan must be established

查看原文本刊更多论文

哈萨克斯坦阿拉木图市因 COVID-19 入院的慢性肾病患者的死亡率及其风险因素

目的：确定哈萨克斯坦阿拉木图市住院治疗的 COVID-19 慢性肾病患者的死亡率及其风险因素。方法：回顾性分析的对象包括 2020 年 6 月至 2022 年 6 月期间在哈萨克斯坦阿拉木图地区一家医院住院治疗的冠状病毒感染患者。国家统一电子医疗系统（UNEHS）提供数据库提取。如果住院患者的主要诊断为 U07.1（COVID-19，检测到病毒）和 U07.2，则符合条件。结论本研究评估了哈萨克斯坦阿拉木图患有和未患有慢性肾病的冠状病毒患者的住院治疗结果。分析了合并症和社会人口特征对死亡率的影响。虽然预防和控制慢性肾脏病（CKD）的方法有很多，但同时存在的内科疾病，尤其是导致大流行的病毒，可能会使问题变得更加复杂。因此，为了防止计划外的传染病爆发，必须制定周密的疾病管理计划

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Salud, Ciencia y Tecnología

自引率

0.00%

发文量